Jennison Associates LLC Has $35.67 Million Holdings in Stevanato Group S.p.A. $STVN

Jennison Associates LLC increased its stake in Stevanato Group S.p.A. (NYSE:STVN) by 13.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,772,896 shares of the company’s stock after buying an additional 213,602 shares during the quarter. Jennison Associates LLC’s holdings in Stevanato Group were worth $35,671,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Farther Finance Advisors LLC bought a new stake in Stevanato Group in the 3rd quarter valued at $44,000. First Horizon Corp bought a new position in Stevanato Group during the 3rd quarter worth $50,000. State of Wyoming increased its position in Stevanato Group by 39,216.7% during the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after buying an additional 2,353 shares during the period. Quantbot Technologies LP bought a new position in Stevanato Group during the 3rd quarter worth $68,000. Finally, Van Berkom & Associates Inc. increased its position in Stevanato Group by 50.6% during the 3rd quarter. Van Berkom & Associates Inc. now owns 3,615 shares of the company’s stock worth $93,000 after buying an additional 1,215 shares during the period.

Wall Street Analysts Forecast Growth

STVN has been the topic of several recent research reports. Jefferies Financial Group set a $17.50 price objective on Stevanato Group in a research report on Tuesday, February 10th. Weiss Ratings cut Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 11th. Morgan Stanley lowered their price objective on Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Friday, March 6th. Citigroup lowered their price objective on Stevanato Group from $32.00 to $26.00 and set a “buy” rating on the stock in a research report on Thursday, March 5th. Finally, Wall Street Zen cut Stevanato Group from a “buy” rating to a “hold” rating in a research report on Saturday, February 14th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Stevanato Group presently has a consensus rating of “Hold”.

Stevanato Group Stock Performance

STVN opened at €17.56 on Friday. The firm has a market cap of $5.32 billion, a P/E ratio of 30.28, a price-to-earnings-growth ratio of 1.52 and a beta of 0.75. Stevanato Group S.p.A. has a 52-week low of €12.89 and a 52-week high of €28.00. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.26 and a current ratio of 1.76. The business’s fifty day moving average is €15.00 and its 200-day moving average is €18.94.

Stevanato Group (NYSE:STVN) last released its earnings results on Saturday, February 14th. The company reported €0.18 earnings per share (EPS) for the quarter. The company had revenue of €346.50 million for the quarter. Stevanato Group had a return on equity of 10.44% and a net margin of 11.83%. Sell-side analysts expect that Stevanato Group S.p.A. will post 0.7 EPS for the current fiscal year.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.